Iht Wealth Management, LLC Regenxbio Inc. Transaction History

Iht Wealth Management, LLC

$2.62 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 22, 2022	SELL	$22.29 - $35.04 $180,994 - $284,524	-8,120 Reduced 44.97%	9,937 $263,000
Q1 2022 May 16, 2022	SELL	$24.62 - $34.31 $24,866 - $34,653	-1,010 Reduced 5.3%	18,057 $599,000
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $295,862 - $394,744	9,800 Added 105.75%	19,067 $623,000
Q3 2021 Nov 15, 2021	SELL	$29.09 - $45.68 $174 - $274	-6 Reduced 0.06%	9,267 $388,000
Q2 2021 Aug 16, 2021	SELL	$32.46 - $40.48 $34,699 - $43,273	-1,069 Reduced 10.34%	9,273 $360,000
Q1 2021 May 18, 2021	SELL	$33.61 - $49.95 $70,581 - $104,895	-2,100 Reduced 16.88%	10,342 $353,000
Q4 2020 Feb 17, 2021	SELL	$26.52 - $49.35 $36,332 - $67,609	-1,370 Reduced 9.92%	12,442 $564,000
Q3 2020 Nov 19, 2020	BUY	$27.01 - $40.26 $70,766 - $105,481	2,620 Added 23.41%	13,812 $380,000
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $1,387 - $2,172	50 Added 0.45%	11,192 $412,000
Q1 2020 May 13, 2020	SELL	$21.5 - $54.2 $6,235 - $15,718	-290 Reduced 2.54%	11,142 $361,000
Q4 2019 Feb 18, 2020	BUY	$34.54 - $44.87 $36,957 - $48,010	1,070 Added 10.33%	11,432 $468,000
Q3 2019 Nov 15, 2019	BUY	$31.84 - $50.88 $88,196 - $140,937	2,770 Added 36.49%	10,362 $369,000
Q2 2019 Aug 12, 2019	BUY	$42.0 - $59.29 $88,200 - $124,509	2,100 Added 38.24%	7,592 $390,000
Q1 2019 May 16, 2019	BUY	$40.82 - $62.45 $17,634 - $26,978	432 Added 8.54%	5,492 $315,000
Q4 2018 Feb 15, 2019	BUY	$39.11 - $75.15 $55,536 - $106,713	1,420 Added 39.01%	5,060 $212,000
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $24,050 - $30,395	370 Added 11.31%	3,640 $275,000
Q2 2018 Aug 13, 2018	BUY	$27.2 - $74.35 $88,944 - $243,124	3,270 New	3,270 $235,000

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

43.5M

Call Options Held

58.9K

Put Options Held

58.4K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $420M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.

Account